Manpreet K. Singh, MD, MS - April 20, 2021

"Evolving Neuroscience-Informed Interventions for Pediatric-Onset Mood Disorders"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom 
12:00 pm - 1:00 pm     Program

Zoom Link:
Join Zoom Meeting
https://zoom.us/j/95301637203

Meeting ID: 953 0163 7203
Passcode: 083713

Dr. Singh is Associate Professor of Psychiatry and Behavioral Sciences, and leads a program aimed to accelerate understanding and treatment in youth with or at high risk for developing a major mood disorder.
 
Dr. Singh earned her MD at Michigan State University and her MS at University of Michigan.  She completed her combined residency training in Pediatrics, Psychiatry, and Child and Adolescent Psychiatry at Cincinnati Children’s Hospital Medical Center. After two years of T32 postdoctoral training at Stanford’s Center for Interdisciplinary Brain Sciences Research, she joined the faculty at Stanford in 2009. 
 
Dr. Singh leads a multidisciplinary team that evaluates and treats youth with a spectrum of mood disorders as young as age 2 and well into their 20s. Her NIMH and industry funded studies examine mechanisms underlying mood disorders and apply cutting edge strategies to directly modulate the brain using transcranial magnetic stimulation and real time neurofeedback.  She is also investigating the efficacy and safety of pharmacotherapies and psychotherapies for youth with and at risk for bipolar disorder, such as family focused psychotherapy and mindfulness meditation, to reduce mood symptoms and family stress.  All of these areas of research aim to elucidate core mechanisms underlying mood disorders and how treatment early in life can pave the path to more adaptive outcomes.
 
In her spare time, Dr. Singh enjoys traveling and hiking with her husband and three children, and avidly teaches Indian classical music. 

Learning objectives: 

1. Apply knowledge of how mood symptoms commonly present in youth, including historical perspectives and current state of neuroscience.
2. Utilize current neuroscience knowledge to guide us toward developing better evaluation and treatment strategies for pediatric mood disorders.
3. Integrate knowledge from prior intervention studies (including known placebo effects) to design new clinical trials.
   
   

For Physicians: Saint Francis Health System is accredited by the Oklahoma State Medical Association to sponsor continuing medical education for physicians.
 
Saint Francis Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognize AMA PRA Category 1  credit™. Saint Francis Health System is accredited by the OSMA
 
For Social Workers: Saint Francis Health System is an approved provider of continuing education for social worker through the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1 Clinical. (CEP Number - 20210007)
 
For CADCs and LADCs Saint Francis Health System is accredited as a provider of continuing education programs for CADCs and LADCs through the Oklahoma Board of Licensed Alcohol and Drug Counselors.      (1 hour)
 
The LPC/LMFT board is currently not allowing new applications for events therefore we cannot give out LPC/LMFT credit for this event. We will have a Certificate of Completion showing LPCs/LMFTs completed the course.
 
No need to register, please login day of event with Zoom link above.

For questions, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

Erin A. Hazlett, Ph.D., March 4, 2021

"Studying Emotion Processing in Individuals at Risk for Suicide: Psychophysiological and Neuroimaging Approaches"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom 
12:00 pm - 1:00 pm  CST 
​ 
Dr. Hazlett has a 5-year Research Career Scientist Award from Clinical Science Research and Development (CSR&D) which supports her full-time VA position. She is a member of the Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2) at the James J. Peters VA Medical Center (JJPVA). Dr. Hazlett is also a professor in the Departments of Psychiatry and Neuroscience at Icahn School of Medicine at Mount Sinai (ISMMS). She is the Director of the Cognitive Psychophysiology Laboratory within both the Department of Psychiatry at ISMMS and the MIRECC at the JJPVA. Dr. Hazlett conducts collaborative clinical research using the new JJPVA state-of-the-art 3T Siemens Skyra magnetic resonance imaging (MRI) scanner and also mentors MIRECC Advanced Psychology Fellows on cutting-edge clinical neuroimaging research.

Dr. Hazlett conducts multidisciplinary clinical research using neuroimaging and psychophysiological approaches to examine the neurobiology of psychiatric illness. She primarily examines the neurobiology of attention and emotion processing abnormalities in schizophrenia spectrum disorders, personality disorders, and major depressive disorder. She has received funding for her research from the Department of Veterans Affairs, Department of Defense, National Institutes of Mental Health, and private foundations (e.g., Brain & Behavior Research Foundation). Her current two VA Merit Award grants employ functional and structural fMRI and/or psychophysiology to examine emotion regulation and impulsivity in Veterans at low and high risk for suicide with and without mild traumatic brain injury (mTBI).

Learning objectives: 
 1. Learn about the neurobiology of borderline personality disorder.
 2. Learn about the neurobiology of major depressive disorder.
 3. Learn about psychophysiological and neuroimaging research in these disorders.

Zoom Link:
Join Zoom Meeting
https://zoom.us/j/96135710544

Meeting ID: 961 3571 0544
Passcode: 497486

________________________________________________________________________________

For Physicians: Saint Francis Health System is accredited by the Oklahoma State Medical Association to sponsor continuing medical education for physicians.
 
Saint Francis Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognize AMA PRA Category 1  credit™. Saint Francis Health System is accredited by the OSMA
 
For Social Workers: Saint Francis Health System is an approved provider of continuing education for social worker through the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1 Clinical. (CEP Number - 20200007)
 
For CADCs and LADCs Saint Francis Health System is accredited as a provider of continuing education programs for CADCs and LADCs through the Oklahoma Board of Licensed Alcohol and Drug Counselors.      (1 hour)
 
The LPC/LMFT board is currently not allowing new applications for events therefore we cannot give out LPC/LMFT credit for this event. We will have a Certificate of Completion showing LPCs/LMFTs completed the course.
 
No need to register, please login day of event with Zoom link above.

For questions, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

Tanja Jovanovic, Ph.D., February 16, 2021

"Neurobiological Effects of Trauma in Adults and Children"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom 
12:00 pm - 1:00 pm     Program
​
Tanja Jovanovic, PhD, is a Professor in the Department of Psychiatry and Behavioral Neurosciences and the David and Patricia Barron Chair for PTSD Neurobiology at Wayne State University. Dr. Jovanovic’s research program focuses on the interaction of traumatic experiences, neurophysiology, neuroendocrinology, and genetics in stress-related disorders in adults and children in high-risk populations. She directs the Detroit Trauma Project (www.detroittraumaproject.com), which investigates the impact that urban trauma exposure has on the brain. Her research employs psychophysiological (e.g. fear-potentiated startle, skin conductance response, heart-rate variability) and brain imaging methods (e.g. MRI, fMRI) to investigate biomarkers of risk for trauma-related psychopathology, such as post-traumatic stress disorder (PTSD). Her laboratory developed novel human fear conditioning, fear inhibition, and extinction paradigms for PTSD patients. Dr. Jovanovic is the lead investigator on several federally funded grants from the National Institutes of Health and has an Independent Investigator Award from the Brain and Behaviour Research Foundation. She has published over 100 peer-reviewed papers and served on national and international grant review panels.
​
Learning objectives: 

 1. Describe intermediate phenotypes for PTSD.
 2. Understand impact of trauma on brain and behavior.
 3. Discuss utility of brain-based biomarkers.
 
Zoom Link:

Topic: WKW Frontiers in Neuroscience - Tanja Jovanovic, Ph.D. - February 16, 2021
Time: Feb 16, 2021 12:00 PM Central Time (US and Canada)

Join Zoom Meeting
https://zoom.us/j/97638857323

Meeting ID: 976 3885 7323
Passcode: 929508

For Physicians: Saint Francis Health System is accredited by the Oklahoma State Medical Association to sponsor continuing medical education for physicians.
 
Saint Francis Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognize AMA PRA Category 1  credit™. Saint Francis Health System is accredited by the OSMA
 
For Social Workers: Saint Francis Health System is an approved provider of continuing education for social worker through the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1 Clinical. (CEP Number - 20200007)
 
For CADCs and LADCs Saint Francis Health System is accredited as a provider of continuing education programs for CADCs and LADCs through the Oklahoma Board of Licensed Alcohol and Drug Counselors.      (1 hour)
 
The LPC/LMFT board is currently not allowing new applications for events therefore we cannot give out LPC/LMFT credit for this event. We will have a Certificate of Completion showing LPCs/LMFTs completed the course.
 
No need to register, please login day of event with Zoom link above.

For questions , email:  Lauren Haguewood at lehaguewood@saintfrancis.com
​

Ned H. Kalin, M.D., February 2, 2021

"The Childhood Risk to Develop Anxiety and Depression:  A Translational Neuroscience Approach"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom (email for link)
12:00 pm - 1:00 pm     Program

Ned H. Kalin, M.D. is Hedberg Professor and Chairman of the Department of Psychiatry at the University of Wisconsin School of Medicine and Public Health.  He is the Director of the HealthEmotions Research Institute and the Lane Neuroimaging Laboratory, a Professor in the Department of Psychology at the University of Wisconsin, and an affiliate scientist at the Wisconsin Reginal Primate Center and the Harlow Primate Laboratory.  He serves as the principal investigator for several ongoing NIH funded research projects and has published over 250 peer-reviewed articles related to the adaptive and maladaptive expression of emotion and anxiety, and the childhood risk to develop anxiety disorders and depression.  His research focuses on uncovering basic mechanisms that relate stress to the development of psychopathology and to understanding the mechanisms that cause some children to be vulnerable for the development of anxiety and depression.  The aim of his research is to develop novel, neuroscientifically-informed strategies for the treatment of anxiety disorders with a special focus on early life and preventive interventions for young children.  In addition to his research activities, he treats patients who suffer from anxiety and depression who are refractory to standard treatment.

Dr. Kalin earned his medical degree from Jefferson Medical School in Philadelphia, Pennsylvania, did his residency in the Department of Psychiatry at the University of Wisconsin, and a fellowship in Neuropsychopharmacology at the National Institute of Mental Health. Dr. Kalin is board certified by the American Board of Psychiatry and Neurology. He is a Fellow Emeritus of the American College of Neuropsychopharmacology and a fellow of the American College of Psychiatry. He has been recognized for numerous awards including the 1985 A.E. Bennett Award for basic science research in biological psychiatry, the 2005 Edward A. Strecker Award, the 2007 American College of Psychiatrists Award for research in mood disorders, the 2007 Gerald Klerman Senior Investigator Award, and the 2015 AnnaMonika Prize of the European College of Neuropsychopharmacology. In 2013 he was inducted as a Fellow in theAmerican Association for the Advancement of Science, and in 2015 he was elected as a member of the National Academy of Medicine. In 2017, Dr. Kalin was inducted as a Distinguished Life Fellow of the American Psychiatric Association. He has served as President of the International Society of Psychoneuroendocrinology and President of the Society of Biological Psychiatry, as a member of the National Advisory Mental Health Council and as Co-Editor for the international journal, Psychoneuroendocrinology. In 2019, Dr. Kalin was appointed as the Editor-in-Chief of the American Journal of Psychiatry.
Learning objectives: 

 1. Recognize early life risk factors to develop anxiety and depression.
 2. Describe brain alterations associated with childhood illness.
 3. Consider ideas about treatment informed by neuroscientific evidence.

Peter L. Strick, Ph.D., January 19, 2021

"The Neural Basis of the 'Brain-Body' Connection"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom (email for details) 
12:00 pm - 1:00 pm     Program

Peter L. Strick, Ph.D., Thomas Detre Professor and Chair, Department of Neurobiology; Scientific Director, University of Pittsburgh Brain Institute; Co-Director, Center for Neuroscience, University of Pittsburgh.

Peter L. Strick, Ph.D., received his B.A. (Biology, 1968) and Ph.D. (Anatomy, 1972) from the University of Pennsylvania. Then, he was a Staff Fellow in Edward V. Evarts’ Laboratory of Neurophysiology at NIMH (1972-1976). In 1976, Strick moved to the VA Medical Center, Syracuse, NY and the Departments of Neurosurgery and Physiology, SUNY-Upstate Medical Center. He was appointed George W. Perkins, III Memorial Professor in Neurosurgery (1988) and served as Acting President of the Central New York Research Corp. (1994-1996), and Interim Director of the Neuroscience Program at SUNY-Upstate (1997-1998).

In 2000, Strick moved to the University of Pittsburgh to become Co-Director, Center for the Neural Basis of Cognition and Professor, Departments of Neurobiology, Neurological Surgery, Physical Medicine & Rehabilitation, and Psychiatry. In 2007, Strick became the founding Director of the Systems Neuroscience Center at the University of Pittsburgh Medical School. In 2012, Strick was appointed the Thomas Detre Professor and Chair, Department of Neurobiology and co-director for the Center for Neuroscience. Strick also was appointed the founding Scientific Director of the University of Pittsburgh Brain Institute (2014-).

Strick co-founded the Neural Control of Movement Society (1990) and served as its Conference Co-Chair, Program Chair (1990-2007) and President (2007-2010). He was elected, Scientific Councilor (1996-2000) and Treasurer (1998-2000) of the Society for Neuroscience. He served as Section Editor (1986-1995) and then Editor-in-Chief, Journal of Neurophysiology (1995-2002), and he currently serves as Senior Editor, Cerebral Cortex (2003-) and on the PNAS Editorial Board (2016-).

Strick's major awards include the C.J. Herrick Award from the American Association of Anatomists (1979); Javits Neuroscience Investigator Award from NIH-NINDS (1986); Established Investigator Award from NARSAD (1995-1996); President's Award for Excellence and Leadership in Research, SUNY-Upstate Medical Center (1996); Senior Research Career Scientist Award from the Veterans Administration (1987-2015); University Distinguished Professor of Neurobiology (2011) and Chancellor's Distinguished Research Award, Senior Scholar, University of Pittsburgh (2013); Linné Lecture, Uppsala University (2017); Paul D. MacLean Award, American Psychosomatic Society (2018); Carnegie Science Award in the Life Sciences, (2018); and the Krieg Cortical Kudos Discoverer Award, Cajal Club (2019). Strick was elected to the American Academy of Arts and Sciences (2004) and to the National Academy of Sciences (2012).

Strick's research focuses on four major areas: the generation and control of voluntary movement by the motor areas of the cerebral cortex; the motor and cognitive functions of the basal ganglia and cerebellum; the neural basis for the mind-body connection; and unraveling the complex neural networks that comprise the central nervous system.

Learning objectives: 

 1. Identify the types of cortical areas that influence the function of the adrenal medulla.
 2. Identify the areas of the cerebral cortex that influence sympathetic output of the stomach.
 3. Identify the areas of the cerebral cortex that influence parasympathetic output to the stomach.
 

Yael Niv, Ph.D., November 18, 2020

"Latent Causes, Prediction Errors, and the Organization of Memory"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom (email for details)
12:00 pm - 1:00 pm     Program

Yael Niv received her MA in Psychobiology from Tel Aviv University and her PhD in Computational Neuroscience from the Hebrew University in Jerusalem, having conducted a major part of her thesis research at the Gatsby Computational Neuroscience Unit in UCL. She is currently a professor at Princeton University, at the Psychology Department and the Princeton Neuroscience Institute. Her lab's research focuses on the neural and computational processes underlying reinforcement learning and decision making, with a particular focus on how the cognitive processes of attention, memory and learning interact in constructing task representations that allow efficient learning and decision making. She is co-founder and co-director of the Rutgers-Princeton Center for Computational Cognitive Neuropsychiatry, where she is applying ideas from reinforcement learning to questions pertaining to psychiatric disorders within the new field of computational psychiatry. 

Learning objectives: 

1. Participants will understand what is a latent cause in learning theory.
2. Participants will understand why latent causes are useful in organizing memories.
3. Participants will understand the role of prediction errors in segmenting latent causes and, therefore, in organizing episodic memories

Jennifer Blackford, Ph.D., October 6, 2020

"What Causes Anxiety?  Building a Reverse Translational Model"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Virtual Presentation via Zoom 
12:00 pm - 1:00 pm     Program
Dr. Blackford is a Professor of Psychiatry and Behavioral Sciences and Vanderbilt University Medical Center, a Professor of Psychology at Vanderbilt University, and a Research Scientist at the Tennessee Valley VA. Dr. Blackford obtained her PhD in Developmental Psychology from Vanderbilt University, followed by training in neuroimaging and genetics, supported by a National Institute of Mental Health Mentored Career Development Award. Dr. Blackford's research is focused on identifying and characterizing the neurobiological basis of anxiety and the role of anxiety neurocircuitry in psychiatric disorders including PTSD, alcohol use disorders, and schizophrenia. She uses multi-modal and multi-level approaches. Multiple imaging methods are used to characterize brain structure, function, and connectivity. To provide a comprehensive assessment of anxiety, data are collected at the level of the brain, physiology, and behaviors. The long term goal of this research program is to use these discoveries to develop new prevention strategies for children at high-risk for developing psychiatric disorders and new treatments for individuals suffering with these disorders.
​
Learning objectives: 

 1. Compare the difference between fear and anxiety.
 2. State challenges for translating rodent findings to humans.
 3. Discuss the BNST's role in anxiety and addiction. 

Judson Brewer, M.D., Ph.D., March 3, 2020

"One Simple Ingredient for Habit Change:  Awareness"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program
​
Jud Brewer MD PhD is the Director of Research and Innovation at the Mindfulness Center and associate professor in Behavioral and Social Sciences at the School of Public Health and Psychiatry at the Medical School at Brown University. He also is a research affiliate at MIT.

A psychiatrist and internationally known expert in mindfulness training for addictions, Brewer has developed and tested novel mindfulness programs for behavior change, including both in-person and app-based treatments for smoking, emotional eating, and anxiety. He has also studied the underlying neural mechanisms of mindfulness using standard and real-time fMRI, and source-estimated EEG, and is currently translating these findings into clinical use (see www.drjud.com for more information).

He has published numerous peer-reviewed articles and book chapters, presented to the US President’s Office of National Drug Control Policy, foreign Parliaments, trained US Olympic athletes and coaches, and foreign government ministers and has been featured on 60 minutes, at TED (4th most viewed talk of 2016 with over 14 Million views), in Time magazine (top 100 new health discoveries of 2013), Forbes, Businessweek, NPR, National Geographic, and the BBC among others. He is the author of The Craving Mind: from cigarettes to smartphones to love, why we get hooked and how we can break bad habits (New Haven: Yale University Press, 2017). Follow him on twitter @judbrewer.

Learning objectives: 
1. Understand how habits are formed and perpetuated.
2. Discuss how mindfulness can help us step out of our old habits.
3. Learn how mindfulness can change our default brain patterns.

Please register for the lunch/lecture by calling or emailing:
Lauren Haguewood
Phone (918) 494-6490
Email: lehaguewood@saintfrancis.com 

​Janet Treasure, M.D., Ph.D.
​February 4, 2020
" Translational Research in Anorexia;  Relevant Results for the Everyday Practice "

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program
​
Janet Treasure, M.D., Ph.D., completed her medical degree and a PhD in Physiology at St. Thomas’ Medical School in London. For much of her career, Dr. Treasure specialized in the treatment of eating disorders at the Maudsley Hospital and in King’s College London. She has carried out extensive research - often collaboratively with patients and carers- which led to a greater understanding of, and better treatments for eating disorders. 

Dr. Treasure has trained over 40 PhD students who have implemented various aspects of translational psychiatry as part of their research training.  Many of these have progressed to hold important academic and clinical positions in eating disorders. She worked collaboratively with other international centres and has authored over 600 scientific articles. 
As well as writing professional texts, Dr. Treasure co-produced self-care interventions (in books and e-health formats) for people affected by eating disorders and their careers and received many awards for her research. 
​
Learning objectives: 

 1. Review the cognitive interpersonal model.
 2. Discuss predisposing and precipitating factors.
 3. Understand how can we target perpetuating factors in treatment. 

Peter Kalivas, Ph.D., November 19, 2019
"Using the Neuroscience of Willpower to Treat Addiction"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program

Peter Kalivas, Ph.D. is a neuropharmacologist best known for his work to elucidate the brain molecules and neurocircuitry that underlie drug addiction.  His research has identified new brain mechanisms that have become potential pharmacotherapeutic targets for treating addiction in clinical trials. He is a Distinguished University Professor and founding Department Chair of Neuroscience at the Medical University of South Carolina in Charleston. He was President of the American College of Neuropsychopharmacology in 2014.  He received his Ph.D. in Pharmacology from the University of Washington in Seattle in 1980, and during a postdoctoral fellowship at the University of North Carolina in Chapel Hill (1980-82) he became oriented towards the role that brain circuitry plays in the regulating behavior. In his first faculty position at Louisiana State University in New Orleans (1982-84) and during a more extensive tenure at Washington State University (1984-98) he came to career research focus on the cellular and molecular underpinnings of the brain circuits mediating addiction. 
​
Learning objectives:  

1. Understand the role of will power in regulating addictive behavior.
2. Understand the neurobiology of how drugs of abuse alter brain circuits to weaken will power.
3. Understand the latest thinking and experimental treatments for how to manipulate will power circuitry to promote abstinence.

Read Montague, Ph.D.

"Tilting Back to Neurobiology: Computational Psychiatry in an Invasive Setting"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
10:00 am - 10:45 am    Registration and Brunch, brunch stops being served at 10:45 - no exceptions
11:00 am - 12:00 pm    Program

Read Montague, Ph.D. is the director of the Human Neuroimaging Lab and Computational Psychiatry Unit at the Fralin Biomedical Research Institute at VTC in Roanoke, Virginia. Dr. Montague’s work focuses on computational neuroscience – the connection between physical mechanisms present in real neural tissue and the computational functions that these mechanisms embody. His early theoretical work focused on the hypothesis that dopaminergic systems encode a particular kind of computational process, a reward prediction error signal, similar to those used in areas of artificial intelligence like optimal control. In pursuit of testing these ideas in humans, Montague founded the Human Neuroimaging Lab at Baylor College of Medicine in Houston, Texas, and pursued functional neuroimaging experiments analogous to those used in other model species.

In 2011, Dr. Montague received a Principal Research Fellowship from The Wellcome Trust and became a principal at The Wellcome Centre for Neuroimaging at University College London (UCL). At UCL, he also serves as adjunct faculty at the Gatsby Computational Neuroscience Unit and participating faculty member of the University College London/Max Planck Institute Centre for Computational Psychiatry and Ageing.

He is actively engaged in translating computational neuroscience into the domain of mental health through work in Computational Psychiatry. His group has recently pioneered new approaches to sub-second neurotransmitter measurements in conscious humans. Over the past decade, he was a member of the MacArthur Foundation Network on Neuroscience and Law with a particular interest in the mental states project(s). His laboratory uses theoretical, computational and experimental approaches to the problems of mental health and its derangement by disease and injury. Work in the laboratory is supported by the National Institutes of Health, National Science Foundation, The Kane Family Foundation, Autism Speaks, The MacArthur Foundation, The Dana Foundation and The Wellcome Trust.

Learning Objectives:
1. Discuss how two-party games of monetary exchange between humans help to identify traditionally-defined psychopathology groups.
2. Learn about new extensions to electrochemistry now available for use in conscious humans.
3. Understand that connection between dopamine and serotonin signaling and their putative computational function in reward learning.

Richard J. Davidson, Ph.D.

"Cultivating Well-Being: Perspectives from Affective and Contemplative Neuroscience"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program

Dr. Richard Davidson received his Ph.D. from Harvard University and has been at The University of Wisconsin Madison since 1984. He has published more than 400 articles, numerous chapters and reviews and edited 14 books. He is the author (with Sharon Begley) of The Emotional Life of Your Brain published by Penguin in 2012. He is co-author with Daniel Goleman of Altered Traits: Science Reveals How Meditation Changes Your Mind, Brain and Body, published by Penguin Books in 2017. He is the recipient of numerous awards for his research and was the year 2000 recipient of the most distinguished award for science given by the American Psychological Association – the Distinguished Scientific Contribution Award. He was the founding co-editor of the new American Psychological Association journal EMOTION and is past-president of the Society for Research in Psychopathology and of the Society for Psychophysiological Research. Dr. Davidson’s research is broadly focused on the neural bases of emotion and emotional style and methods to promote human flourishing including meditation and related contemplative practices. His studies have included persons of all ages from birth though old age and have also included individuals with disorders of emotion, such as mood and anxiety disorders and autism, as well as expert meditation practitioners with tens of thousands of hours of experience. His research uses a wide range of methods including different varieties of MRI, positron emission tomography, electroencephalography and modern genetic and epigenetic methods.

Learning Objectives
1. Identify four important constituents of well-being.
2. Discuss the brain circuits that underlie these constituents.
3. Understand the different forms of meditation practice that impact well-being and its neural bases.

Nora Volkow, M.D., Director of the National Institute on Drug Abuse, NIH

"Drug Addiction as a Disease of the Human Brain"
12:00 pm - 1:00 pm
Laureate Psychiatric Clinic and Hospital Conference Center 

Nora Volkow M.D., is Director of the National Institute on Drug Abuse at the National Institutes of Health (NIH). Over the past 30 years, she has published more than 770 peer-reviewed articles, more than 95 book chapters, edited four books on brain imaging and addiction and co-edited an Encyclopedia on Neuroscience. She has received multiple awards including membership in the National Academy of Medicine in 2000 and the International Prize for Science from the French Institute of Health and Medical Research in 2009. She was named one of Time magazine’s “Top 100 People Who Shape Our World”, “One of 20 People to Watch”, by Newsweek magazine and “Innovator of the Year” by U.S. News & World Report. Her work as a researcher and as a leader has been instrumental in transforming the paradigm of drug addiction from that of a behavioral choice to that of a treatable brain disease.

Marc Schuckit, M.D.

"A 35-Year Longitudinal Study of Risk Factors for Alcoholism"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
10:00 am - 10:45 am    Registration and Brunch, brunch stops being served at 10:45 - no exceptions
11:00 am - 12:00 pm    Program

Dr. Marc A. Schuckit is a distinguished Professor of Psychiatry at the University of California, San Diego. His work regarding substance use and related disorders has focused primarily on risk factors for developing heavy drinking and alcohol use disorders (AUDs); how genetic and environmental contributors toward this risk can operate through a low level of response (low LR) to alcohol and how such data can be used to help prevent alcohol-related problems; fMRI-based brain mechanisms that contribute to this low response; and longitudinal studies of individuals at high risk for AUDs. He has also published about the development of diagnostic criteria for substance use disorders (SUDs) overall. Dr. Schuckit developed the concept of an AUD risk through the low level response (LR) to alcohol, established methodologies and designs for assessing the construct and tested LR across populations (e.g., adolescents, adults, females, males) and across generations in the U.S. and U.K. The causes of heavy drinking and alcohol problems are many and identifying these is an important endeavor. Dr. Schuckit has maintained a strong interest in issues related to alcohol and other substance-related disorders, both from the standpoint of diagnosis as chair of the DSM-IV and member of the DSM-5 SUD workgroups and by producing overviews of clinically relevant topics as published in the New England Journal of Medicine and Lancet, including overviews of delirium tremens, treatments for AUDs and the treatment of opioid use disorders.

Learning Objectives:
1. Understand the role of genetic contributors to alcoholism.
2. Learn about the role of the low level of response to alcohol as an endophenotype enhancing the alcoholism risk.
3. Discuss how such risk factors can be used to help prevent heavy drinking and alcohol problems.

Carlos A. Zarate, M.D.

"Deconstructing the Neurobiology of Mood Disorders using Rapid Acting Antidepressant and Antisuicidal Ideation Interventions as a Bridge to Novel Therapeutics"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program

Carlos A. Zarate, M.D. is Chief of the Experimental & Therapeutics Branch and of the Section on Neurobiology and Treatment of Mood and Anxiety Disorders, and Senior Tenured Clinical Investigator, Division Intramural Research Program, National Institute of Mental Health, Clinical Professor of Psychiatry and Behavioral Sciences, George Washington University and Professor of Psychiatry and Behavioral Sciences, Howard Medical School.
​
Carlos A. Zarate, M.D. is Chief Experimental Therapeutics & Pathophysiology Branch and of the Section on Neurobiology and Treatment of Mood and Anxiety Disorders, Division Intramural Research Program, National Institute of Mental Health. Dr. Zarate completed his residency training in psychiatry at the Massachusetts Mental Health Center/Brockton VAMC division. He later completed a fellowship in Clinical Psychopharmacology at McLean Hospital of the Consolidated Department of Psychiatry, Harvard Medical School and remained on staff at McLean Hospital as the Director of the Bipolar and Psychotic Disorders Outpatient Services. From 1998 to 2000 Dr. Zarate was the Chief of the Bipolar and Psychotic Disorders Program at the University of Massachusetts Medical School. In 2001, he joined the Mood and Anxiety Disorders Program at NIMH. His achievements and awards include the Ethel-DuPont Warren Award and Livingston Awards, Consolidated Department of Psychiatry, Harvard Medical School; Outstanding Psychiatrist Research Award, Massachusetts Psychiatric Association; Program for Minority Research Training in Psychiatry, APA; the National Alliance for Research on Schizophrenia and Depression Young Investigator Award; National Alliance for Research on Schizophrenia and Depression Independent Investigator Award; the National Institutes of Health Director’s Award Scientific/Medical, the 2011 Brain & Behavior Research Foundation Award for Bipolar Mood Disorder Research, the 2013 National Institute of Health Director’s Award—Scientific/Medical Achievement and Mogens Schou Research Award: Bipolar Disorder and the Simon-Bolivar Award American Psychiatric Association; 2015 Ruth L. Kirschtein Mentoring Award NIH and the Astute Clinician Lecture Award, NIH. Dr. Zarate is a fellow of the American College of Neuropsychopharmacology and member of the Society of Biological Psychiatry and the Society for Neuroscience. Dr. Zarate’s research focuses on the pathophysiology and development of novel therapeutics for treatment-resistant mood disorders as well as the study of biomarkers and neural correlates of treatment response.

Learning objectives: 

1. Discuss the causes of treatment-resistant depression.
2. Become familiar with research on treatment-resistant depression, particularly with ketamine and other glutamatergic modulators.
3. To understand research on biomarkers of treatment response.

 
For Physicians: CME credit will be given.

For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognizes AMA PRA Category 1 credit™.  

For Social Workers: This event has been approved by the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1Clinical.  (CEP Number - 20150007)

For LPCs and LMFTs: An application has been made to the State Board of Behavioral Health Licensure (BBHL) for 1 hour of CE.

For CADCs and LADCs: Laureate Psychiatric Clinic and Hospital, Tulsa, Oklahoma, is accredited as a provider of continuing chemical dependency education by the State of Oklahoma - Board of Licensed Alcohol and Drug Counselors for 1 hour of CE.                                     
REGISTER TO ATTEND!

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

Distinguished Speakers
​
Jason Beaman, D.O. 
Chair, Department of Psychiatry and Behavioral Sciences OSUCHS

Gerard Clancy, M.D.
President, University of Tulsa

Sarah W. Feldstein Ewing, Ph.D. 
Oregon Health & Science University, Director, Adolescent Behavioral Health Clinic

Francesca Filbey, Ph.D.
University of Texas at Dallas, School of Behavioral and Brain Science

Scott Grantham, M.D. 
Medical Director, Laureate Psychiatric Clinic and Hospital

Kent Hutchinson, Ph.D. 
University of Colorado Boulder, The Center for Health and Addiction: Neuroscience, Genes, and Environment

Martin Paulus, M.D.
Scientific Director, Laureate Institute for Brain Research

Susan Tapert, Ph.D.
University of California at San Diego, Department of Psychiatry

Terri White, M.S.W
Commissioner, Office of Mental Health and Substance Abuse

Accreditation Statements:
​
CADC’s and LADC’s: Saint Francis Health System is an approved provider of continuing education programs for CADC’s and LADC’s through the Oklahoma Board of Licensed Alcohol and Drug Counselors and has approved this program for (5.5 hours)

LPCS/LMFTs: An approval request has been sent into the State Board of Behavioral Health Licensure (BBHL) for 5.5 hours of CE.

Physicians: Saint Francis Health System is accredited by the Oklahoma State Medical Association to sponsor continuing medical education for physicians
Saint Francis Health System designates this live activity for a maximum of 5.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognizes this event, Cannabis: What we have Learned through Scientific Research at TU Lorton Center on January 17, 2018 for 5.5 AMA PRA Category 1 Credit. Saint Francis Health System is an Accredited through OSMA.

Social Workers: This event, “Cannabis: What we have Learned through Scientific Research” at TU Lorton Center on January 17, 2018 has been approved by the Oklahoma State Board of Licensed Social Workers for 5.5 hours Category 1 Clinical. (CEP Number- 20190007)
​

"Chronobiology of Women's Mood Disorders"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program
​
Barbara L. Parry, M.D. is Professor of Psychiatry at the University of California, San Diego (UCSD) where she has served as Director of the Women’s Mood Disorders Clinic of the UCSD Outpatient Psychiatric Services and the La Jolla Psychiatry Specialty Clinics, Director of the Women’s Mental Health Clinic at the San Diego Veterans Administration Healthcare Center and Associate Director of the Consultation-Liaison Service and the Medical Student Clerkship in Psychiatry.  Before joining the faculty at UCSD in 1985, she did a Research Fellowship in Clinical Psychobiology at the National Institute of Mental Health in Bethesda, Maryland.  She completed a Residency in Psychiatry and an Internship in Internal Medicine at the University of California, Los Angeles.  Her clinical research focus is the chronobiology of mood disorders specific to women: premenstrual, peripartum and menopausal depression.  She conducts sleep, light, melatonin and other hormonal studies with the aim of developing complementary sleep and light therapy approaches to treatment.  Her work is supported by NIH funding, she has authored or co-authored over 300 publications and served on NIH study sections, Data and Safety Monitoring Boards and the Editorial Boards of the American Journal of Psychiatry, the Journal of Biological Rhythms, the International Journal of Endocrinology and Equilibria, the Journal for Postpartum Psychiatric Illness Research and Menopause, The Journal of the North American Menopause Society.
 
Learning objectives: 
 .

1. Identify sleep and circadian rhythm abnormalities in women's mood disorders.
2. Determine effects of sleep and light treatments.
3. Differentiate pathogenesis and treatment response in premenstrual, peripartum and menopausal depression.

 
For Physicians: CME credit will be given.

For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognizes AMA PRA Category 1 credit™.  

For Social Workers: This event has been approved by the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1Clinical.  (CEP Number - 20150007)

For LPCs and LMFTs: An application has been made to the State Board of Behavioral Health Licensure (BBHL) for 1 hour of CE.

For CADCs and LADCs: Laureate Psychiatric Clinic and Hospital, Tulsa, Oklahoma, is accredited as a provider of continuing chemical dependency education by the State of Oklahoma - Board of Licensed Alcohol and Drug Counselors for 1 hour of CE.                                     
REGISTER TO ATTEND!

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

David Barlow, Ph.D.
"Transdiagnostic Approaches to Treating Neuroticism & Somatic Anxiety in Emotional Disorders"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program

David H. Barlow is Professor of Psychology and Psychiatry, Emeritus and the Founder of the Center for Anxiety and Related Disorders at Boston University. He has published over 600 articles and chapters and over 80 books and clinical manuals. He is the recipient of numerous awards, including honorary degrees from the University of Vermont and William James College, and the two highest awards in psychology, the Distinguished Scientific Award for Applications of Psychology from the American Psychological Association and James McKeen Cattell Fellow Award from the Association for Psychological Science honoring individuals for their lifetime of significant intellectual achievements in applied psychological research.
 
Learning objectives: 

1. Anxiety, mood and related disorders can be conceptualized as disorders of emotion.
2. Disorders of emotion have common identifiable underlying mechanisms.
3. Transdiagnostic treatments targeting these mechanisms may be more efficient and effective interventions than treatment programs targeting just a single diagnosis.
   ​

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com